Tuesday - October 27, 2026

Hereditary Angioedema Market Size Expected to Climb Sharply by 2036, Fueled by Increasing Diagnosis Rates and Therapeutic Innovation | KalVista Pharma, Intellia Therapeutics, BioMarin Pharma, CSL

The Key Hereditary Angioedema Companies in the market include – KalVista Pharma, CSL Behring, Intellia Therapeutics, ADARx Pharma, Attune Pharma, Ionis Pharmaceuticals, Astria Therapeutics, BioMarin Pharmaceutical, CSL Behring, Pharvaris Netherlands B.V, Takeda, CSL Behring, Shire, and others.   (Albany, New … Continue reading →

Attention Deficit Hyperactivity Disorder Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Afecta Pharma, ABVC BioPharma, Mind Medicine, Neurocentria

(Albany, New York) – October 27, 2026: As per DelveInsight’s assessment, globally, Attention Deficit Hyperactivity Disorder pipeline constitutes 20+ key companies continuously working towards developing 22+ Attention Deficit Hyperactivity Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →